Assessment of Hydration Status Using Bioelectrical Impedance Vector Analysis
NCT ID: NCT02936440
Last Updated: 2016-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
224 participants
OBSERVATIONAL
2011-05-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tailored Hydration Based on Bioimpedance Analysis for Prevention of Contrast Induced Acute Kidney Injury
NCT04215042
Effects of Vena Cava Inferior Measurements on AKI and Mortality.
NCT06331234
Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care
NCT06799910
BIA Guided-fluid Management in Postinjury Open Abdomen
NCT03466684
BIA-Guided vs. Conventional Fluid Resuscitation in ICU Patients
NCT07142083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
critical patients with AKI
Critical patients with AKI will be followed up to 12 weeks after diagnosis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catholic University of Pelotas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Cristina Gonzalez
Full Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Cristina Gonzalez, MD, PhD
Role: STUDY_CHAIR
Catholic University of Pelotas
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009/79
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.